{"id": "applied_medium_1", "question": "What is the main focus of section 14.11 Administrative Requirements IIB-112 in the NIH Grants Policy Statement?", "prediction": "The main focus of **Section 14.11 Administrative Requirements IIB-112** in the NIH Grants Policy Statement (NIHGPS) is to specify **additional or alternate administrative requirements** that apply to particular NIH grant awards or activities. This section is part of **Part IIB** of the NIHGPS, which expands on or supplements the general terms and conditions found in **Part IIA** by addressing administrative requirements unique to certain types of awards, recipients, or activities.\n\nKey points about Section 14.11 and its context within the NIHGPS include:\n\n1. **Supplement to General Terms:**  \n   Section 14.11 provides administrative requirements that go beyond the general terms and conditions applicable to all NIH awards outlined in Part IIA. These requirements are tailored to ensure proper administration and compliance for specific grant types or activities (SYNTHESIS).\n\n2. **Recipient Responsibilities and Compliance:**  \n   The section likely details recipient responsibilities related to grant administration, compliance with NIH policies, and management of awarded funds and activities. This ensures that recipients meet both NIH-specific policies and overarching federal regulations (SYNTHESIS).\n\n3. **Relation to Federal Regulations:**  \n   The administrative requirements in Section 14.11 are in addition to statutory and regulatory requirements such as those in 2 CFR Part 200. The NIHGPS terms, including those in Section 14.11, serve as aids to interpreting these requirements but do not override them. In case of conflict, statutes and regulations govern (SYNTHESIS, Documents 5-8).\n\n4. **Incorporation by Reference:**  \n   The terms and conditions in Part II, including Section 14.11, are incorporated by reference into all NIH grant and cooperative agreement awards. This means that recipients are contractually bound to comply with these administrative requirements as part of their award terms (Documents 5-8).\n\n5. **Purpose:**  \n   The overarching purpose of Section 14.11 is to ensure **proper administration and compliance** with NIH policies for specific grant types or activities, thereby supporting effective management and oversight of NIH funds (SYNTHESIS).\n\n6. **Context within NIHGPS:**  \n   - The NIHGPS is organized into three parts: Part I (General Information), Part II (Terms and Conditions), and Part III (Points of Contact).  \n   - Part II is divided into IIA (general terms) and IIB (specific or additional terms). Section 14.11 falls under IIB, indicating its role in specifying terms for particular awards or activities (Documents 9-10).\n\n**In summary:**  \nSection 14.11 Administrative Requirements IIB-112 focuses on defining **specific administrative requirements** that supplement the general NIH grant terms and conditions. These requirements address the unique administrative responsibilities and compliance obligations of recipients for certain NIH grant awards or activities, ensuring adherence to NIH policies and federal regulations.\n\n---\n\n**References:**  \n- SYNTHESIS summary of NIHGPS structure and Section 14.11 focus  \n- Documents 5-8: Detailed explanation of Part II, IIA and IIB terms and conditions, incorporation by reference, and compliance requirements  \n- Documents 9-10: NIHGPS introduction and organizational structure"}
{"id": "applied_medium_2", "question": "What are the requirements and review process for transitioning from the K99 phase to the R00 phase in the NIH Pathway to Independence Award?", "prediction": "The NIH Pathway to Independence Award (K99/R00) is a two-phase award designed to help postdoctoral investigators transition to stable independent research positions with independent funding. The transition from the K99 phase (mentored career development) to the R00 phase (independent research support) involves specific requirements and a defined review process as outlined below.\n\n### Requirements for Transitioning from K99 to R00 Phase\n\n1. **Securing an Independent Position:**\n   - The K99 award recipient must secure a tenure-track, full-time assistant professor position or an equivalent independent research position to be eligible for transition to the R00 phase. (Documents 1, 2, 3, 4, Section 12.2.3.2.3)\n   \n2. **Duration of K99 Support:**\n   - Generally, the K99 phase lasts up to 2 years.\n   - Awardees are expected to receive at least 12 months of mentored career development support before transitioning.\n   - Early transition (before 2 years) is possible if an acceptable independent position is secured, but this requires prior NIH approval. (Documents 5, 6, 7, 8, Section 12.2.3.2.2)\n   \n3. **No Independence Before K99 Start:**\n   - If an applicant achieves independence prior to starting the K99 phase, neither the K99 nor the R00 phase will be awarded. (Documents 5, 6, 7, 8, Section 12.2.3.2.2)\n   \n4. **No Gap Between Phases:**\n   - There should be no delay or gap between the end of the K99 phase and the start of the R00 phase. (Documents 1, 2, 3, 4, Section 12.2.3.2.3)\n   \n5. **No-Cost Extensions:**\n   - No-cost extensions for the K99 phase may be granted with prior NIH approval if additional time is needed to complete career development goals.\n   - During a no-cost extension, all award terms remain in effect.\n   - Recipients continuing to seek an independent position during a no-cost extension must submit a plan for continued career development and timely transition.\n   - If an R00 application with a suitable position is not submitted within one year of the no-cost extension, the R00 phase will not be awarded. (Documents 5, 6, 7, 8, Section 12.2.3.2.2)\n   \n6. **Carryover of Funds:**\n   - Carryover of funds from the K99 to the R00 phase may be allowed if the K99 phase was funded by extramural support, but recipients should consult the awarding Institute or Center (IC) for specific policies. (Documents 5, 6, 7, 8, Section 12.2.3.2.2)\n\n### Review Process for Transition\n\n1. **Administrative Review:**\n   - The transition application to the R00 phase is subject to an administrative review by NIH staff.\n   - This transition application is **not** peer-reviewed by a study section. (Documents 1, 2, 3, 4, Section 12.2.3.2.3)\n   \n2. **Contingent Approval:**\n   - Transition to the R00 phase is not guaranteed and is contingent upon NIH approval of the transition application and securing an appropriate independent position. (Documents 1, 2, 3, 4, Section 12.2.3.2.3)\n   \n3. **Expectations During R00 Phase:**\n   - R00 award recipients are expected to compete successfully for independent NIH R01 funding during the R00 phase. (Documents 1, 2, 3, 4, Section 12.2.3.2.3)\n\n### Summary\n\n- The K99 phase provides up to 2 years of mentored support, with a minimum of 12 months expected before transition.\n- To transition, the awardee must secure a tenure-track or equivalent independent research position.\n- The transition application undergoes administrative (non-peer) review by NIH staff.\n- No gap is allowed between K99 and R00 phases.\n- No-cost extensions for K99 are possible with NIH approval, but R00 application must be submitted within one year of extension.\n- Carryover of funds may be possible, subject to IC policies.\n- The R00 phase provides up to 3 years of independent research support, with the expectation of competing for R01 funding.\n\nFor more detailed information, the NIH New Investigators Program website under the Pathway to Independence Award is recommended: http://grants.nih.gov/grants/new_investigators/#indaward (Documents 1-4).\n\n---\n\n**References:**\n\n- Documents 1-4, Section 12.2.3.2.3 (Transition to the R00 Phase)\n- Documents 5-8, Section 12.2.3.2.2 (K99 Phase details and transition conditions)\n- Documents 9-10, Section 12.2.3.2 (Overall K99/R00 program description)"}
{"id": "applied_medium_3", "question": "What is the purpose of a waiver under section 11.4.3.4 of the NIH Grants Policy Statement?", "prediction": "The purpose of a waiver under section 11.4.3.4 of the NIH Grants Policy Statement (NIHGPS) is to provide the National Institutes of Health (NIH) with the authority and flexibility to modify or exempt certain standard terms and conditions of NIH grant awards when justified by specific circumstances. This waiver mechanism allows NIH to accommodate unique management, administrative, or programmatic concerns that may arise in particular awards or recipients, where strict application of the standard policies may not be appropriate or feasible.\n\nKey points about the purpose of the waiver include:\n\n- **Flexibility in Application:** Waivers enable NIH to apply statutory, regulatory, or policy requirements flexibly to particular awards or recipients without conflicting with overarching laws. This helps NIH address special situations that require deviations from the usual terms and conditions.  \n- **Compliance with Higher-Level Requirements:** While waivers allow for exceptions, they remain consistent with maintaining compliance with governing statutes and regulations, such as 2 CFR Part 200. In cases of conflict between statutes/regulations and the NIHGPS terms, statutes and regulations govern, and waivers help resolve or prevent such conflicts by officially permitting deviations.  \n- **Supplementing or Modifying Terms:** The NIH Grants Policy Statement and award-specific terms and conditions may be supplemented or modified by waivers to address unique concerns, ensuring effective grant management while adhering to federal requirements.  \n- **Recipient Responsibility:** Recipients of NIH grants remain responsible for complying with all applicable requirements unless a waiver explicitly provides relief from certain terms or conditions.  \n- **Administrative Tool:** Waivers are part of NIH\u2019s administrative tools to ensure effective grant management and to respond to circumstances that warrant exceptions to standard policies.\n\nIn summary, the waiver under section 11.4.3.4 serves as an official mechanism for NIH to grant exceptions or modifications to standard grant terms and conditions to address special circumstances, ensure alignment with higher-level legal requirements, and facilitate effective and flexible grant administration (SYNTHESIS).\n\nAdditional context from the NIHGPS indicates that the terms and conditions of NIH grants are generally incorporated by reference in all awards and are intended to supplement, not substitute for, governing statutory and regulatory requirements. The NIHGPS is designed to be compliant with statutes and regulations but allows for previously approved waivers and deviations to modify these terms when necessary (Documents 1-4).\n\nTherefore, the waiver mechanism is essential for balancing the need for consistent grant administration with the flexibility to address unique or unforeseen situations in NIH grant management.\n\n**References:**  \n- SYNTHESIS summary of section 11.4.3.4 of the NIH Grants Policy Statement  \n- Documents 1-4: Part II Terms and Conditions of NIH Grants and Cooperative Agreements"}
{"id": "applied_medium_4", "question": "What is the significance of the Initiation of Support as described in section 11.3.7 of the NIH Grants Policy Statement?", "prediction": "The significance of the Initiation of Support as described in section 11.3.7 of the NIH Grants Policy Statement (NIHGPS) lies in its role as the formal and official commencement of NIH grant funding availability to the recipient. This initiation marks the date when NIH grant funds become accessible and when the recipient is authorized to begin incurring costs charged to the grant. Several key points highlight its importance:\n\n1. **Official Start Date for Funding and Costs**: The Initiation of Support establishes the official start date when NIH grant funds are made available to the recipient. This means that the recipient may only begin to incur allowable costs charged to the grant from this date forward. Costs incurred before this date are generally not allowable unless specifically authorized by NIH (SYNTHESIS).\n\n2. **Requirement of NIH Approval**: The initiation of support cannot occur until NIH has approved the Notice of Award (NoA). The NoA serves as the formal document that authorizes the start of funding and the recipient\u2019s activities under the grant (SYNTHESIS).\n\n3. **Compliance with Terms and Conditions**: The initiation date is critical for ensuring compliance with the grant\u2019s terms and conditions, including adherence to budget periods and project timelines. It aligns the recipient\u2019s project activities with the availability of NIH funding, ensuring proper grant management (SYNTHESIS).\n\n4. **Trigger for Recipient Responsibilities**: Once support is initiated, the recipient assumes responsibilities such as timely reporting, adherence to NIH policies, and proper use of funds. This initiation thus marks the point at which the recipient must fully comply with all NIH grant requirements (SYNTHESIS).\n\n5. **Alignment with NIH Grants Policy Framework**: The NIHGPS consolidates all policy requirements and terms and conditions for NIH grants, which apply to recipients and flow down to subrecipients. The initiation of support is a foundational event within this framework, ensuring that all subsequent activities and obligations are properly timed and managed according to NIH policies (Documents 1-4).\n\nIn summary, the Initiation of Support is significant because it formally authorizes the recipient to begin grant-supported activities and expenditures, ensures alignment with NIH funding and policy requirements, and triggers the recipient\u2019s compliance obligations under the grant award. This ensures proper stewardship of NIH funds and adherence to the legal and administrative framework governing NIH grants.\n\n**References:**\n- NIH Grants Policy Statement, Section 11.3.7 (SYNTHESIS)\n- NIH Grants Policy Statement, Introduction and Organization (Documents 1-4)"}
{"id": "applied_medium_5", "question": "Can a mentored Career Development Award (CDA) be transferred to another institution with a new mentor, and what approvals are required?", "prediction": "Yes, a mentored Career Development Award (CDA) can be transferred to another domestic institution with a new mentor, but certain conditions and approvals are required.\n\n**Key points regarding transferability and requirements:**\n\n1. **Transferability:**  \n   - Individual mentored CDAs (such as K01, K07, K08, K22, K23, K25, K99/R00) can be transferred to another domestic institution.  \n   - The awardee (PD/PI) remains the same; the award may not be transferred to another PD/PI (i.e., the recipient cannot be changed) (Documents 5, 9, 10; Section 12.12).\n\n2. **Mentor Requirement:**  \n   - The recipient must have a mentor at the new institution.  \n   - If the transfer involves a change of mentor, supporting documentation from the new mentor is required to demonstrate the mentoring plan and support (Documents 5, 6, 7, 8, 9, 10; Section 12.12).\n\n3. **Approvals Required:**  \n   - Approval from the NIH awarding Institute or Center (IC) is required for any transfer of the CDA to another institution or for any project change (Documents 9, 10; Section 12.12).  \n   - Consultation with NIH program staff and/or grants management staff is strongly encouraged when considering a transfer to ensure compliance and smooth processing (Documents 5, 6, 7, 8).\n\n4. **Compliance with NIH Policies:**  \n   - Transfers must comply with NIH Change of Recipient Organization policies as described in the NIH terms (Documents 9, 10).  \n   - All terms and conditions of the award, including full-time appointment and minimum effort requirements, must continue to be met during any extension or transfer period (Documents 5, 6, 7, 8).\n\n**Summary:**  \nA mentored CDA can be transferred to another domestic institution with a new mentor, provided that the recipient remains the same PD/PI. The transfer requires NIH awarding IC approval and supporting documentation from the new mentor if there is a change in mentorship. It is highly recommended to consult NIH program and grants management staff before initiating the transfer process to ensure all requirements and policies are met.\n\n**References:**  \n- Definition and transferability of mentored CDAs: Documents 1-4 (Section 12.2.2)  \n- Transfer requirements and approvals: Documents 5-10 (Section 12.12)"}
{"id": "applied_medium_6", "question": "How should salaries and fringe benefits be handled in NIH grant budgets according to section 12.8.1?", "prediction": "According to NIH grant policies summarized in section 12.8.1 and related terms and conditions, salaries and fringe benefits in NIH grant budgets must be handled as follows:\n\n1. **Alignment with Institutional Policies and Accounting Principles**  \n   Salary and fringe benefit requests must be consistent with the institution\u2019s established policies that are applied uniformly to all similar employees, regardless of funding source. They must also be supported by acceptable accounting principles (2 CFR Part 200.430(i)) and documented through an adequate payroll distribution system. Compensation must be reasonable and reflect the actual percentage of effort devoted to the NIH-funded project (SYNTHESIS; Documents 3, 4, 5, 6).\n\n2. **Salary Limits and Caps**  \n   Salary costs charged to NIH grants cannot exceed the applicable legislative salary cap set by NIH, which varies by Institute or Center and is specified in the Notice of Funding Opportunity (NOFO). Fringe benefits are provided in addition to salary and are not subject to this salary cap (SYNTHESIS).\n\n3. **Salary Basis and Proration**  \n   For Career Development Awards (CDAs), salary requests must be based on the investigator\u2019s institutional base salary (IBS) prorated to the percentage of effort committed to the project. If full-time 12-month salaries are not standard at the institution, the proposed salary must relate appropriately to the existing salary structure (SYNTHESIS).\n\n4. **Salary Supplementation**  \n   Recipient institutions may supplement NIH salary contributions up to their institutional salary scale, but supplementation must come from non-Federal sources (e.g., institutional funds). Public Health Service (PHS) funds cannot be used for salary supplementation. Supplementation must not require additional duties that interfere with the goals of the CDA (SYNTHESIS).\n\n5. **Effort and Total Compensation Limits**  \n   Total salary paid from all sources for an individual may not exceed 100% of their regular institutional salary. Compensation must reasonably reflect the percentage of time devoted to the NIH-funded project. For effort not committed to the CDA, compensation may be received from other Federal or non-Federal grants if the project aims differ (SYNTHESIS; Documents 3, 4, 5, 6).\n\n6. **Fringe Benefits**  \n   Fringe benefits include leave (vacation, sick, family-related, military), employee insurance, pensions, unemployment benefits, and similar allowances. These costs are allowable if they are reasonable and required by law, employee agreement, or institutional policy. Tuition remission for students working on grant-supported projects is allowable under specific conditions, such as the student being enrolled in an advanced degree program and the tuition remission being consistent with institutional policy and reasonable compensation for work performed (Documents 1 and 2).\n\n7. **Restrictions on Use of Funds**  \n   Salaries of federal employees with permanent appointments are generally unallowable except in certain cases. Additionally, funds budgeted for salary and fringe benefits that become available due to an individual receiving a K award (Career Development Award) may not be used for other purposes without prior NIH approval (Documents 7, 8, 9, 10).\n\nIn summary, NIH grant budgets for salaries and fringe benefits must adhere to institutional policies and federal cost principles, respect NIH salary caps, properly document effort and compensation, allow supplementation only from non-Federal sources, and ensure fringe benefits are reasonable and allowable. Special rules apply for Career Development Awards, including proration of salary and restrictions on the use of funds freed up by receiving a K award.\n\n**References:**  \n- SYNTHESIS section summarizing 12.8.1 requirements  \n- Documents 1 and 2: Fringe benefits policies and tuition remission conditions  \n- Documents 3, 4, 5, 6: Salary documentation, allowability, and effort requirements  \n- Documents 7, 8, 9, 10: Restrictions on use of funds when a K award is received"}
{"id": "applied_medium_7", "question": "How should an organization allocate indirect costs such as depreciation, interest, operation and maintenance, and general administration according to 2 CFR Part 200.1?", "prediction": "According to 2 CFR Part 200, an organization should allocate indirect costs such as depreciation, interest, operation and maintenance, and general administration by following a structured process involving the creation of an indirect cost pool and the use of a modified total direct cost (MTDC) base for allocation. The key steps and principles are as follows:\n\n1. **Definition of Indirect Costs**  \n   Indirect costs are those incurred for common or joint objectives that cannot be readily identified with a specific final cost objective. Examples include depreciation, interest, operation and maintenance, and general administration expenses (2 CFR Part 200, Appendix III, Section B.1; Synthesis).\n\n2. **Formation of the Indirect Cost Pool**  \n   The organization pools indirect costs into an indirect (Facilities & Administrative, F&A) cost pool. This pool typically includes:  \n   - General administration and general expenses (excluding student-related costs such as student administration, activities, aid, and scholarships).  \n   - Operation and maintenance of the physical plant and depreciation, after appropriate adjustments for costs applicable to other institutional activities.  \n   - Library expenses.  \n   - Department administration expenses, computed as 20% of the salaries and expenses of deans and department heads (2 CFR Appendix-III-to-Part-200, 3.b.F.2; Documents 1-4).\n\n3. **Establishment of the Distribution Base (Modified Total Direct Cost - MTDC)**  \n   The distribution base consists of all direct functions of the institution but excludes certain items such as capital expenditures, equipment, and scholarships. This base is called the Modified Total Direct Cost (MTDC) base (Synthesis; Documents 1-4).\n\n4. **Calculation of the Indirect Cost Rate**  \n   The indirect cost rate is calculated by dividing the total amount in the indirect cost pool by the MTDC base:  \n   \\[\n   \\text{Indirect Cost Rate} = \\frac{\\text{Indirect Cost Pool}}{\\text{MTDC Base}}\n   \\]  \n   This rate represents the proportion of indirect costs relative to direct costs and is used to allocate indirect costs to individual agreements or projects (2 CFR Appendix-III-to-Part-200, 3.b.F.2.c-d; Documents 1-4).\n\n5. **Application of the Indirect Cost Rate**  \n   The organization applies the indirect cost rate to the MTDC of individual agreements or projects to determine the allocable indirect costs for each agreement. This ensures that indirect costs are allocated fairly and consistently across all benefitted functions (2 CFR Appendix-III-to-Part-200, 3.b.F.2.e; Documents 1-4).\n\n6. **Special Considerations**  \n   - Separate indirect cost pools and rates may be established for segments of work with significantly different indirect cost levels, such as different physical locations, administrative support levels, or scientific disciplines. This is to ensure accuracy when indirect costs vary materially across segments (2 CFR Appendix-III-to-Part-200, 5.C; Documents 9-10).  \n   - Indirect cost rates may be predetermined, fixed, or final, with specific definitions and implications for adjustments (Documents 9-10).\n\n7. **Documentation and Certification**  \n   - Indirect cost rate proposals must follow standard formats available from the Office of Management and Budget (OMB).  \n   - Authorized officials must certify that the reported expenditures and indirect costs are true, complete, and in accordance with award documents. This certification is required on fiscal reports or vouchers requesting payment under agreements (2 CFR Appendix-III-to-Part-200, 3.b.E-F; Documents 1-4).\n\n**Summary:**  \nAn organization allocates indirect costs by pooling all indirect expenses (including depreciation, interest, operation and maintenance, and general administration) into an indirect cost pool, excluding direct costs and certain exceptions. It then establishes a Modified Total Direct Cost base representing all direct costs eligible for allocation. The indirect cost rate is computed by dividing the indirect cost pool by the MTDC base. This rate is applied to the MTDC of individual agreements to allocate indirect costs proportionally. Proper documentation and certification ensure compliance and accuracy. Separate rates may be used for distinct segments of work with materially different indirect cost structures (2 CFR Part 200, Appendix III and IV; Documents 1-10).\n\n---\n\n**References:**  \n- 2 CFR Appendix-III-to-Part-200, Sections 3.b.E-F (Documents 1-4)  \n- 2 CFR Appendix-III-to-Part-200, Section 5.C (Documents 9-10)  \n- Synthesis of retrieved documents"}
{"id": "applied_medium_8", "question": "What are the key reporting requirements outlined in section 11.3.13 of the NIH Grants Policy Statement?", "prediction": "The key reporting requirements outlined in section 11.3.13 of the NIH Grants Policy Statement (NIHGPS) focus primarily on the submission of progress reports and the reporting of publications resulting from NIH-funded research. Although the exact text of section 11.3.13 was not directly retrieved, the synthesis of relevant excerpts from the NIH Grants Policy Statement documents provides a comprehensive overview of these requirements:\n\n1. **Progress Reports**  \n   - Recipients of NIH grants must submit annual and final progress reports to the NIH awarding Institute or Center (IC).  \n   - These reports serve to document the progress of the funded research or activities, ensuring that NIH can monitor the use of funds and the advancement of the project.  \n\n2. **Publications Reporting**  \n   - Publications that arise from NIH-funded research must be included as part of the progress reports.  \n   - When publications are available electronically, the recipient must provide the URL or the PubMed Central reference number (PMCID) to comply with NIH requirements.  \n   - If publications are not electronically available, a physical copy may be submitted along with the progress report.  \n\n3. **Compliance with NIH Public Access Policy**  \n   - Reporting must align with the NIH Public Access Policy, which mandates that publications resulting from NIH funding be made accessible to the public.  \n   - This ensures transparency and broad dissemination of research findings supported by NIH funds.  \n\n4. **Purpose of Reporting Requirements**  \n   - These requirements are designed to promote transparency, accountability, and the dissemination of research findings.  \n   - They help NIH ensure that funds are used appropriately and that the outcomes of funded research are shared with the scientific community and the public.\n\nWhile the retrieved documents do not provide the verbatim text of section 11.3.13, the above points summarize the key reporting obligations as described in the NIH Grants Policy Statement and related excerpts (see [SYNTHESIS] and general NIH Grants Policy Statement introduction in Documents 9 and 10).\n\n**References:**  \n- [SYNTHESIS] Key Reporting Requirements in Section 11.3.13 of the NIH Grants Policy Statement  \n- NIH Grants Policy Statement Introduction (Documents 9 and 10)  \n\nNo additional specific details about section 11.3.13 were found in the other retrieved documents."}
{"id": "applied_medium_9", "question": "If you have a question about NIH grant policies, which office and contact should you reach out to according to section 1986?", "prediction": "According to Section 1986 of the NIH Grants Policy Statement (NIHGPS), if you have a question about NIH grant policies, you should contact the Grants Management Officer (CGMO) or the designated extramural program official of the NIH Institute or Center (IC) that is relevant to your grant. These contacts are listed in Part III: Points of Contact of the NIHGPS, which provides the names, offices, and contact information for these officials (see Documents 5, 6, 7, and 8, all from Part III: Points of Contact).\n\nKey points include:\n\n- For general questions about NIH grant policies, reach out to the CGMO or extramural program official listed for the specific NIH IC in Part III of the NIHGPS.\n- For questions related to a particular application or grant award, you should contact the individual(s) named in formal NIH communications such as the Notice of Award (NoA) (Documents 5-8).\n- The addresses provided in Part III should not be used for express or hand deliveries; instead, contact the IC to obtain the correct express mail address (Documents 5-8).\n- Part III also includes the web addresses for each IC\u2019s home page, which can be useful for finding additional contact information (Documents 5-8).\n- The NIHGPS is organized into three parts, with Part III specifically dedicated to Points of Contact, including offices and officials responsible for NIH grants (Documents 9 and 10).\n\nIn summary, Section 1986 directs you to consult Part III of the NIHGPS for the appropriate contacts, primarily the CGMO or extramural program official of the relevant NIH IC, and to use formal NIH communications for application or grant-specific inquiries.\n\n**References:**\n\n- Section 1986 summary and Part III: Points of Contact (Documents 5-8)\n- NIHGPS organization and Part III description (Documents 9 and 10)"}
{"id": "applied_medium_10", "question": "Where should I send paper competing applications for NIH grant review?", "prediction": "To submit paper competing applications for NIH grant review, you should send them to the specific NIH Institute or Center (IC) that is responsible for awarding the grant. The exact mailing address for paper submissions is not directly provided in the documents, and it is important to obtain the correct address from the relevant IC before sending your application.\n\nKey points and instructions based on the retrieved documents:\n\n1. **Definition of Competing Applications:**  \n   Competing applications include New Applications (Type 1), Renewal Applications (Type 2), and other types that must compete for funding through peer review (Documents 5 and 6, Section 2.3.4).\n\n2. **Contact the Relevant NIH Institute or Center:**  \n   Since each IC manages its own grant submissions, you must contact the specific IC to get the correct mailing address for submitting paper applications. This ensures your application is sent to the right place and processed correctly (SYNTHESIS; Documents 7-10, PART III: POINTS OF CONTACT).\n\n3. **Use the NIH Grants Policy Statement (NIHGPS) Part III for Contact Information:**  \n   Part III of the NIHGPS provides contact information for each IC, including the Contact Grants Management Officer (CGMO) and extramural program officials. This section also includes the web addresses for the ICs\u2019 home pages, which can be useful for obtaining further details (Documents 7-10).\n\n4. **Do Not Use Part III Addresses for Express or Hand Deliveries Without Confirmation:**  \n   The addresses listed in Part III should not be used for express mail or hand deliveries unless you have confirmed with the IC the appropriate address for such deliveries. Always verify the correct address for express or courier services directly with the IC (SYNTHESIS; Documents 7-10).\n\n5. **Follow Instructions in Official NIH Communications:**  \n   For requests related to particular applications, always follow the instructions and contact information provided in formal NIH communications such as the Notice of Award (NoA) or other official correspondence (SYNTHESIS; Documents 7-10).\n\n**Summary:**  \n- Identify the NIH Institute or Center relevant to your grant application.  \n- Contact the IC\u2019s Grants Management Officer or extramural program official using the contact information in the NIH Grants Policy Statement Part III.  \n- Obtain the correct mailing address for paper submission from the IC.  \n- Do not rely on the addresses in Part III for express or hand deliveries without prior confirmation.  \n- Follow any specific instructions provided in official NIH communications related to your application.\n\nThis approach ensures your paper competing application is sent to the correct location for NIH peer review and funding consideration.\n\n**References:**  \n- NIH Grants Policy Statement, Part III: Points of Contact (Documents 7-10)  \n- Section 2.3.4 Types of Applications (Documents 5 and 6)  \n- Synthesis summary of submission guidance"}
{"id": "applied_medium_11", "question": "What is the primary focus of the Public Health Security IIA-46 requirement in NIH grants?", "prediction": "The primary focus of the Public Health Security IIA-46 requirement in NIH grants is to ensure that NIH grant recipients comply with public policy requirements related to public health security. This requirement is part of the NIH Grants Policy Statement (NIHGPS), specifically within Part II (IIA), which covers generally applicable terms and conditions of NIH grant awards.\n\nKey points about the Public Health Security IIA-46 requirement include:\n\n1. **Compliance with Public Health Security Policies:** The requirement mandates adherence to policies that protect public health and safety in the conduct of NIH-funded research and activities. This means that recipients must conduct their research and related activities in ways that do not compromise public health security.\n\n2. **Applicability:** It applies to all NIH grant recipients and flows down to subawards and subrecipients unless otherwise specified. This ensures that all parties involved in NIH-funded projects uphold the same standards regarding public health security.\n\n3. **Supplement to Other Policies:** Public Health Security IIA-46 supplements other applicable public policy requirements and objectives specified in the NIH Grants Policy Statement, reinforcing the overarching mission of NIH grants.\n\n4. **Alignment with NIH Mission:** The requirement supports the NIH mission to enhance health, lengthen life, and reduce illness and disability through biomedical and behavioral research. Public health security is a critical component of this mission, ensuring that research activities do not pose risks to public health.\n\n5. **Regulatory Framework:** NIH grants are governed by federal regulations (2 CFR Part 200) and HHS policies, with the NIHGPS consolidating these requirements into a single document for clarity and accessibility (Documents 5, 6, 7, 8, 9, and 10).\n\n6. **Further Details:** Specific details or additional criteria related to Public Health Security IIA-46 may be outlined in program guidelines, Notices of Funding Opportunity (NOFO), or other NIH documents, indicating that recipients should consult these sources for comprehensive compliance information.\n\nIn summary, Public Health Security IIA-46 is focused on ensuring that NIH-funded research and activities are conducted in a manner that safeguards public health and safety, aligning with the NIH's broader mission and regulatory framework. This requirement is a fundamental part of the terms and conditions that govern NIH grant awards and applies broadly to all recipients and their subrecipients (SYNTHESIS; Documents 5-10).\n\n**References:**\n- NIH Grants Policy Statement (NIHGPS), Part II (IIA) \u2013 Terms and Conditions of NIH Grant Awards (Documents 5-8)\n- SYNTHESIS summary of Public Health Security IIA-46 requirement\n- NIH mission and regulatory framework (Documents 9 and 10)"}
{"id": "applied_medium_12", "question": "What is the main objective of the merit review process that Federal agencies must design and execute for discretionary Federal awards?", "prediction": "The main objective of the merit review process that Federal agencies must design and execute for discretionary Federal awards is to select the recipients who are most meritorious. This means the process is intended to objectively evaluate applications and identify those applicants who best meet the agency\u2019s standards and criteria for awarding funds (Documents 1, 2, 3, 4).\n\nMore specifically, the merit review process is an objective evaluation conducted according to written agency standards. These standards define how applications are assessed, including the number and diversity of reviewers involved\u2014ensuring participation from a broad and diverse group, including representatives from underserved communities (Documents 5, 6, 7, 8). The process must be transparent and clearly described in agency documentation, detailing how merit review outcomes influence final award decisions, whether the review results are advisory or determinative, and who makes the final selections (Documents 9, 10).\n\nIn summary, the merit review process aims to ensure fairness, transparency, and objectivity in awarding discretionary Federal funds by:\n\n- Using clearly defined evaluation criteria and sub-criteria with disclosed relative importance and any statutory preferences (Documents 7, 8).\n- Engaging qualified, diverse reviewers selected to avoid conflicts of interest (Documents 7, 8).\n- Providing a documented, multi-phase or single-phase review process as appropriate (Documents 9, 10).\n- Ensuring that the most meritorious applicants are selected based on merit rather than other non-merit factors, although programmatic considerations (e.g., geographic dispersion, program balance, diversity) may also be factored in by selecting officials beyond merit scores (Documents 7, 8).\n\nThus, the fundamental goal is to objectively and transparently identify and select the best-qualified recipients for discretionary Federal awards (Documents 1\u201310).\n\n**References:**  \n- 2 CFR \u00a7 200.205 (Documents 1\u20134)  \n- 2 CFR 200.205 detailed explanation (Documents 5\u20138)  \n- 2 CFR Appendix I to Part 200 (Documents 9, 10)"}
{"id": "applied_medium_13", "question": "Where should I send correspondence related to grant compliance for NIH grants?", "prediction": "Correspondence related to grant compliance for NIH grants should be sent to the specific NIH Institute or Center (IC) that awarded the grant. The appropriate contacts within the IC include the Contact Grants Management Officer (CGMO) and the extramural program official responsible for the grant. \n\nKey points to consider:\n\n1. **Specific NIH IC Contact**:  \n   - You should direct your correspondence to the NIH IC that awarded your grant. Each IC has designated officials for grant management and programmatic issues.  \n   - For general inquiries, contact the extramural program official listed for the awarding IC.  \n   - For specific questions about your particular application or grant award, direct correspondence to the individual(s) named in formal NIH communications such as the Notice of Award (NoA) (SYNTHESIS; Documents 9 and 10, PART III: POINTS OF CONTACT).\n\n2. **NIH Grants Policy Statement (NIHGPS) Part III**:  \n   - Part III (chapter 20) of the NIHGPS provides detailed contact information for the CGMO and extramural program officials for each IC.  \n   - This part also includes the web addresses for each IC\u2019s home page, which can be useful for obtaining updated contact information.  \n   - The NIHGPS is available online and users are encouraged to consult Part III for the most current points of contact related to grant compliance (SYNTHESIS; Documents 5, 6, 7, 8, 9, 10).\n\n3. **Mailing Addresses and Delivery Instructions**:  \n   - The addresses listed in the NIHGPS Part III should not be used for express mail or hand deliveries.  \n   - You should contact the IC directly to obtain the correct address for express or hand deliveries to ensure proper receipt of your correspondence (SYNTHESIS; Documents 9 and 10).\n\n**Summary:**  \nTo send correspondence related to NIH grant compliance, identify the NIH Institute or Center that awarded your grant. Address your correspondence to the CGMO or extramural program official listed in the NIH Grants Policy Statement Part III or as specified in your Notice of Award. For express or hand deliveries, contact the IC to obtain the correct mailing address. The NIHGPS Part III is the authoritative source for up-to-date contact information and should be consulted online for the latest details.\n\n**References:**  \n- NIH Grants Policy Statement (NIHGPS), Part III: Points of Contact (Documents 5, 6, 7, 8, 9, 10)  \n- SYNTHESIS summary of retrieved documents"}
{"id": "applied_medium_14", "question": "Where can I find the specific appropriation mandates that limit the use of NIH grant funds for a given fiscal year?", "prediction": "The specific appropriation mandates that limit the use of NIH grant funds for a given fiscal year are statutory provisions derived from the annual HHS appropriation Act. These mandates impose restrictions on how NIH grant, cooperative agreement, and contract funds may be used, reflecting social, economic, or other policy objectives attached to Federal fund expenditures. Because these mandates can change annually based on the language of the HHS appropriation Act, it is important to consult the most current information for the relevant fiscal year.\n\n**Where to Find the Specific Appropriation Mandates:**\n\n1. **NIH Office of Extramural Research (OER) Website:**  \n   A list of appropriation mandates applicable to each fiscal year is posted on the NIH OER website. This is the primary and up-to-date source for the specific mandates that apply to NIH grant funds in any given fiscal year.  \n   - This is explicitly stated in multiple documents (Documents 1, 2, 3, 4, all Section 4.2), which note:  \n     *\"A list of Appropriation Mandates applicable to each fiscal year can be found on the OER web site.\"*\n\n2. **NIH Policy Documents \u2013 \"Appropriation Mandates\" Section:**  \n   NIH policy documents include a dedicated section titled \"Appropriation Mandates\" (Section 4.2 in the documents provided) where these statutory provisions are summarized. This section explains the nature of the mandates, their basis in the HHS annual appropriation Act, and their applicability to NIH awards.  \n   - Documents 1 through 4 (Section 4.2) and Documents 5 through 8 (Section 4) provide detailed context about these mandates and their role in ensuring responsible use of Federal funds.\n\n**Additional Context:**\n\n- The appropriation mandates complement other public policy requirements and Federal grant regulations that NIH recipients must follow (Documents 5-8, Section 4).  \n- They are intended to minimize improper financial gain, conflicts of interest, and to promote safe and high-quality research environments.  \n- Because the mandates may be updated or new ones added annually, it is critical to consult the current fiscal year's list on the OER website to ensure compliance.\n\n**Summary:**\n\nTo find the specific appropriation mandates limiting the use of NIH grant funds for a given fiscal year, you should:\n\n- Visit the NIH Office of Extramural Research (OER) website and locate the list of appropriation mandates for the relevant fiscal year.  \n- Review the \"Appropriation Mandates\" section (Section 4.2) in NIH policy documents, which provides statutory context and summaries of these mandates.\n\nThis approach ensures you have the most current and authoritative information reflecting the restrictions imposed by the annual HHS appropriation Act.\n\n---\n\n**References:**  \n- Documents 1-4, Section 4.2: Appropriation Mandates and their availability on the OER website.  \n- Documents 5-8, Section 4: Public Policy Requirements, Objectives, and Other Appropriation Mandates."}
{"id": "applied_medium_15", "question": "What distinguishes questioned costs from improper payments under federal grant compliance?", "prediction": "Questioned costs and improper payments are related but distinct concepts under federal grant compliance, differentiated primarily by the stage of review and confirmation regarding the legitimacy of the costs charged to federal awards.\n\n**Questioned Costs:**\n- Defined as costs identified by auditors during audits that are potentially noncompliant with federal requirements. These costs may be \"known\" (directly identified) or \"likely\" (extrapolated from audit samples) questioned costs (see [SYNTHESIS], [Document 1], [Document 2], [Document 3], [Document 4]).\n- Questioned costs represent preliminary findings indicating potential issues with costs charged to federal programs but are not automatically deemed improper payments.\n- Auditors report questioned costs exceeding $25,000 as audit findings in the schedule of findings and questioned costs (see [SYNTHESIS], [Document 9], [Document 10]).\n- Resolution of questioned costs involves negotiation with the cognizant agency, especially for indirect costs, and may include formal or informal processes (see [SYNTHESIS]).\n\n**Improper Payments:**\n- Defined separately and confirmed only after a review process as payments that should not have been made or were made in incorrect amounts under applicable statutory, contractual, administrative, or other legal requirements (see [SYNTHESIS]).\n- The confirmation of improper payments follows the criteria and review process outlined in OMB Circular A-123 Appendix C (see [SYNTHESIS], [Document 1], [Document 2], [Document 3], [Document 4]).\n- Improper payments are a subset of questioned costs that have been reviewed and confirmed to be erroneous or noncompliant payments.\n\n**Key Distinguishing Factors:**\n- **Stage of Determination:** Questioned costs are preliminary audit findings indicating potential noncompliance, whereas improper payments are those questioned costs that have undergone further review and have been confirmed as payments made in error or violation of rules (see [SYNTHESIS], [Document 1] (2 CFR 200.1(6))).\n- **Definition and Confirmation:** Questioned costs are not improper payments until reviewed and confirmed per OMB Circular A-123 Appendix C (see [Document 1], [Document 2], [Document 3], [Document 4]).\n- **Reporting:** Auditors report questioned costs as findings when above thresholds, but improper payments are identified after confirmation and may trigger recovery or corrective actions (see [SYNTHESIS], [Document 9], [Document 10]).\n\nIn summary, questioned costs are audit-identified potential issues with costs charged to federal awards that require further review. Improper payments are those questioned costs that have been formally reviewed and confirmed as payments that should not have been made or were made incorrectly under federal requirements. This distinction ensures that not all questioned costs are immediately treated as improper payments until due process and confirmation occur.\n\n**References:**\n- 2 CFR 200.1 \u201cQuestioned cost\u201d (5) and (6) ([Documents 1-4])\n- OMB Circular A-123 Appendix C (referenced in [SYNTHESIS])\n- Audit reporting requirements and thresholds ([Documents 9], [10])\n- Synthesis summary provided above"}
{"id": "applied_medium_16", "question": "Do the provisions to extend the final budget period without additional funds and carryover of unobligated balances apply to NIH Individual Fellowships?", "prediction": "The provisions to extend the final budget period of a project period without additional NIH funds and the carryover of unobligated balances explicitly **do NOT apply to NIH Individual Fellowships**.\n\n### Key Points:\n\n1. **Applicability to NIH Individual Fellowships:**\n   - Individual Fellowships are awarded under the NIH Standard Terms of Award.\n   - However, the specific provisions that allow recipients to extend the final budget period without additional funds and to carry over unobligated balances are **not applicable** to Individual Fellowships.\n   - This is clearly stated in multiple documents (Documents 1, 2, 3, 4), all referencing Section 11.2.13.8, which explicitly says:\n     > \"Individual Fellowships are awarded under the NIH Standard Terms of Award however the provisions to extend the final budget period of a project period without additional funds and carryover of unobligated balances do not apply.\"\n\n2. **General NIH Policy on Extensions Without Additional Funds:**\n   - For other NIH grant types (not fellowships), recipients may extend the final budget period one time for up to 12 months beyond the original end date without additional funds, provided:\n     - No term of award prohibits the extension.\n     - No additional NIH funds are required.\n     - The project scope remains unchanged.\n   - This extension is intended to complete remaining work or allow orderly closeout.\n   - Notification must be done electronically via the eRA Commons No-Cost Extension feature within 90 days before the project end date.\n   - These details are described in Documents 5, 6, 7, and 8 (Section 8.1.1.3).\n   - However, these provisions explicitly exclude fellowship awards, as stated at the end of these sections:\n     > \"The provisions in this subsection do not apply to fellowship awards.\"\n\n3. **Carryover of Unobligated Balances:**\n   - Similarly, the carryover of unobligated balances is not allowed for Individual Fellowships, as stated in the same sections (Documents 1-4).\n\n### Summary:\n\n- NIH Individual Fellowships **cannot** extend their final budget period without additional funds.\n- NIH Individual Fellowships **cannot** carry over unobligated balances.\n- The no-cost extension policy and carryover provisions that apply to other NIH grants explicitly exclude fellowship awards.\n\n### References:\n\n- Documents 1, 2, 3, 4 (Section 11.2.13.8): Applicability of NIH Standard Terms of Award to Individual Fellowships.\n- Documents 5, 6, 7, 8 (Section 8.1.1.3): Extension of Final Budget Period without Additional NIH Funds (excludes fellowships).\n\nTherefore, if you hold an NIH Individual Fellowship, you should not expect to be able to extend your final budget period without additional funds or carry over unobligated balances under these NIH policies."}
{"id": "applied_medium_17", "question": "Under what conditions can intra-IHE faculty consulting that exceeds a faculty member's base salary be charged to an NIH grant according to section 8.1.1.7?", "prediction": "According to section 8.1.1.7 of the NIH grant terms and conditions, intra-Institution of Higher Education (IHE) faculty consulting that exceeds a faculty member's base salary may be charged to an NIH grant only under specific and unusual conditions. These conditions are as follows:\n\n1. **Nature of the Consulting Work:**\n   - The consulting must be **across departmental lines** or involve a **separate or remote operation** from the faculty member\u2019s regular departmental responsibilities.\n   - The consulting work must be **in addition to the faculty member\u2019s regular departmental load**, meaning it is beyond their usual duties and obligations within their home department or unit.  \n   (See Documents 1, 2, 3, 4, 9, and 10; Section 8.1.1.7)\n\n2. **Approval and Documentation Requirements:**\n   - Such consulting arrangements must be **specifically provided for in the Federal award** or **approved in writing by the NIH awarding Institute or Center (IC)**.\n   - The recipient institution must have **written guidelines** that permit payment of consulting fees to employees, regardless of funding source, and clearly specify the conditions under which consulting fees are proper.\n   - An individual **cannot be paid both as an employee and as a consultant under the same NIH grant**.\n   - Authorization for consulting fees must be **documented in writing on a case-by-case basis** by the head of the organization or their designee who is incurring the costs. If the designee is personally involved in the project, only the head of the organization can provide this authorization.\n   - This authorization must include a determination that the required conditions are met and that there is **no apparent or actual conflict of interest**.  \n   (See Documents 9 and 10; Section 8.1.1.7)\n\n3. **Budgeting:**\n   - These consulting activities and associated charges must be **specifically included in the Federal award budget** to be allowable.  \n   (See Synthesis and Documents 9 and 10)\n\n**Summary:**  \nIntra-IHE faculty consulting charges exceeding base salary are allowable on NIH grants only in unusual cases where the consulting is cross-departmental or involves a separate or remote operation, and the work is additional to the faculty member\u2019s regular duties. Such charges require prior written approval by the NIH awarding IC or inclusion in the award, adherence to institutional policies permitting consulting fees, prohibition of dual payment as employee and consultant under the same grant, and documented authorization by organizational leadership ensuring no conflict of interest. These consulting costs must also be explicitly budgeted in the Federal award.\n\n**References:**  \n- Section 8.1.1.7, Documents 1-4, 9, 10  \n- Synthesis summary provided above"}
{"id": "applied_medium_18", "question": "How are applications from foreign organizations evaluated during the NIH initial review process?", "prediction": "Applications from foreign organizations are evaluated during the NIH initial review process through the same rigorous and standardized procedures applied to domestic applications. The NIH employs a \"dual review system\" consisting of two sequential levels of review:\n\n1. **Initial Review:** Conducted by an Initial Review Group (IRG) or Scientific Review Group (SRG), which assesses the scientific merit of the application.\n2. **Second-Level Review:** Performed by the Institute/Center (IC) National Advisory Council/Board, which reviews the scientific merit and other considerations.\n\nThis process is designed to be fair, equitable, timely, and to minimize bias, as mandated by law (sections 406 and 492 of the Public Health Service Act, NIH Reform Act of 2006, and the 21st Century Cures Act) (Documents 1-4, Section 2.4).\n\n**Key points regarding foreign organization applications:**\n\n- Applications from foreign organizations undergo the *same* peer review process as domestic applications without any special exceptions or separate procedures (SYNTHESIS).\n- The review focuses strictly on scientific merit, with explicit efforts to eliminate bias related to the applicant\u2019s origin (SYNTHESIS).\n- Review panels (IRG/SRG) evaluate applications based on established NIH criteria that apply equally to all applicants, regardless of their geographic or organizational origin (SYNTHESIS).\n- Definitions and policies related to applicant status (e.g., New Investigator) and application types apply equally to foreign and domestic applicants (SYNTHESIS, Document 9).\n\n**Appeals Process:**\n\n- If applicants, including foreign organizations, believe the initial review was procedurally flawed (e.g., evidence of bias, conflict of interest, or lack of appropriate expertise in the review panel), they may submit an appeal.\n- Appeals must be submitted within 30 calendar days after the second-level review and must include concurrence from the Authorized Organization Representative (AOR) (Documents 5-8, Section 2.4.2).\n- The appeal process underscores NIH\u2019s commitment to fairness and objectivity in the peer review system (SYNTHESIS, Documents 5-8).\n\n**Summary:**\n\n- Foreign organization applications are evaluated through NIH\u2019s standard dual-level peer review process.\n- The evaluation is based solely on scientific merit, with strict policies to ensure fairness and eliminate bias.\n- There are no special or separate procedures for foreign applicants during initial review.\n- An established appeal mechanism exists to address any procedural concerns in the initial review.\n\n**References:**\n\n- NIH Peer Review Process Overview and fairness policies: Documents 1-4 (Section 2.4)\n- Evaluation of foreign applications and equity: SYNTHESIS\n- Appeals of initial scientific review: Documents 5-8 (Section 2.4.2)\n- Definitions and applicability of policies to foreign applicants: SYNTHESIS, Document 9\n\nThis comprehensive approach ensures that applications from foreign organizations receive equitable and unbiased consideration during the NIH initial review process."}
{"id": "applied_medium_19", "question": "What are participant support costs according to 2 CFR \u00a7 200.456, and how should they be treated in an indirect cost rate proposal?", "prediction": "According to 2 CFR \u00a7 200.456, **participant support costs** are defined as costs for items such as stipends or subsistence allowances, travel allowances, and registration fees paid to or on behalf of participants or trainees (who are not employees) in connection with conferences, training projects, or similar activities. These costs are considered direct costs related specifically to participants or trainees rather than employees (SYNTHESIS; Documents 1\u20138).\n\nThese costs are allowable under federal awards as per \u00a7 200.1, but their classification as participant support costs must be clearly documented in the recipient\u2019s or subrecipient\u2019s written policies and procedures. Furthermore, these policies must be applied consistently across all federal awards to ensure uniformity in cost classification and treatment (SYNTHESIS; Documents 9 and 10).\n\nRegarding the treatment of participant support costs in indirect cost rate proposals, these costs are generally **excluded** from the base used to calculate indirect cost rates. This means when developing an indirect cost rate, participant support costs should not be included in the cost pool or base unless a special indirect cost rate applies. If a special indirect cost rate is required, appropriate modifications must be made to develop that rate accordingly (SYNTHESIS).\n\nIn summary:\n\n- **Definition:** Participant support costs include stipends, subsistence allowances, travel allowances, registration fees paid to or on behalf of participants or trainees (not employees) in connection with conferences, training, or similar activities (\u00a7 200.456).\n- **Allowability and Documentation:** These costs are allowable and must be documented in written policies and procedures, applied consistently across all federal awards (\u00a7 200.1).\n- **Indirect Cost Rate Treatment:** Participant support costs are excluded from the indirect cost rate base unless a special indirect cost rate is negotiated, in which case modifications are made to develop that rate (\u00a7 200.456).\n\nThis treatment ensures clarity and consistency in cost allocation and reimbursement under federal awards.\n\n**References:**  \n- 2 CFR \u00a7 200.456 Participant support costs (Documents 1\u20138, SYNTHESIS)  \n- 2 CFR \u00a7 200.1 Allowability of costs (Documents 9, 10, SYNTHESIS)"}
{"id": "applied_medium_20", "question": "What factors must be considered when determining if a selected item of cost is allowable under federal grants according to 2 CFR \u00a7 200.420?", "prediction": "When determining if a selected item of cost is allowable under federal grants according to 2 CFR \u00a7 200.420, several key factors must be considered. These factors are grounded in the broader cost principles outlined in 2 CFR \u00a7\u00a7 200.402\u2013200.411 and particularly emphasize the criteria for allowability as detailed in \u00a7 200.403 and related sections. The main considerations include:\n\n1. **General Allowability Criteria (\u00a7 200.403):**  \n   - **Necessity and Reasonableness:** Costs must be necessary for the proper and efficient performance of the federal award and reasonable in amount.  \n   - **Conformance with Limitations:** Costs must conform to any limitations or exclusions set forth in federal regulations or the specific terms of the award.  \n   - **Consistency:** Costs must be consistent with the recipient\u2019s policies and uniformly applied to both federally financed and other activities. For example, a cost treated as a direct cost in one instance should not be treated as an indirect cost in another.  \n   - **Accounting Principles:** Costs must be determined in accordance with generally accepted accounting principles (GAAP), unless otherwise specified.  \n   - **No Double Charging:** Costs must not be included as a cost or used to meet cost sharing or matching requirements of any other federally financed program (2 CFR \u00a7 200.403).\n\n2. **Compliance with Additional Requirements (\u00a7 200.402):**  \n   - Costs must meet the requirements of \u00a7\u00a7 200.402 through 200.411, which provide detailed principles for specific cost items.  \n   - Costs must be properly supported by approved cost allocation plans consistent with applicable cost accounting principles.  \n   - Costs must not be borne directly or indirectly by the Federal Government under another award, preventing duplication of charges (2 CFR \u00a7 200.402(a)-(c)).\n\n3. **Allocability (\u00a7 200.405):**  \n   - Costs must be allocable to the federal award, meaning they are incurred specifically for the award or benefit both the award and other work and can be distributed in reasonable proportion.  \n   - Costs must conform to any limitations or exclusions set forth in the cost principles or the federal award.  \n   - Consistency in treatment across awards and activities is required (2 CFR \u00a7 200.405).\n\n4. **Non-Exclusivity and Case-by-Case Determination (\u00a7 200.420(b)):**  \n   - The list of allowable or unallowable costs is not exhaustive. Failure to mention a particular cost item does not imply allowability or unallowability.  \n   - Each cost item\u2019s allowability should be determined based on the treatment of similar or related costs, considering the principles above (2 CFR \u00a7 200.420(b)).\n\n5. **Specific Examples of Cost Items (NIH Grants, 7.9.1):**  \n   - For example, advertising costs are allowable only if they are solely for the recruitment of personnel required for the federal award. Other advertising costs are generally unallowable (NIH Grants, Section 7.9.1).\n\n**Summary:**  \nTo determine if a selected cost is allowable under federal grants per 2 CFR \u00a7 200.420, the cost must be necessary, reasonable, allocable, consistently treated, conform to federal and award-specific limitations, properly documented, and not charged elsewhere. The determination should also consider how similar costs are treated and adhere to any specific guidance for particular cost types.\n\n**References:**  \n- 2 CFR \u00a7 200.402\u2013200.411 (Documents 1-4)  \n- 2 CFR \u00a7 200.403 (Documents 5-8)  \n- 2 CFR \u00a7 200.405 (Synthesis)  \n- 2 CFR \u00a7 200.420(b) (Documents 1-4, Synthesis)  \n- NIH Grants, Section 7.9.1 on Advertising Costs (Documents 9-10)"}
{"id": "applied_medium_21", "question": "What are the eligibility criteria and duration requirements for short-term research training positions under the T32 institutional research training grant?", "prediction": "The eligibility criteria and duration requirements for short-term research training positions under the T32 institutional research training grant are as follows:\n\n**Eligibility Criteria:**\n\n1. **Target Trainees:**\n   - Medical students, dental students, and students in other health-professional programs.\n   - Graduate students in physical or quantitative sciences such as physics, mathematics, or engineering.\n   - In pharmacy schools, only candidates for the Pharm.D. degree are eligible.\n   \n2. **Enrollment Status:**\n   - Trainees must be enrolled and in good standing in their respective programs.\n   - They must have completed at least one quarter or semester in a relevant degree program before participating in the short-term training.\n   \n3. **Exclusions:**\n   - Individuals already matriculated in a formal research degree program in the health sciences.\n   - Those holding a research doctorate, master\u2019s degree, or a combined professional and research doctorate are normally not eligible for short-term positions.\n   \n4. **Additional Notes:**\n   - Short-term positions are intended to provide health-professional students with opportunities to participate in biomedical, behavioral, or clinical research to attract them into research careers.\n   - Since some NIH Institutes and Centers (ICs) do not support or limit support for short-term research training positions under T32, applicants are urged to contact the relevant NIH IC before requesting short-term positions in their T32 application (Documents 5, 6, 7, 8, Section 11.3.2.5.3).\n\n**Duration and Appointment Requirements:**\n\n1. **Length of Appointment:**\n   - Short-term research training positions should last at least 8 weeks but no more than 12 weeks.\n   - These appointments typically occur during the summer or other \u201coff-quarter\u201d periods.\n   \n2. **Full-Time Requirement:**\n   - All short-term training must be full time, generally defined as at least 40 hours per week.\n   - Part-time training is generally not permitted for short-term positions.\n   \n3. **Multiple Appointments:**\n   - Trainees are encouraged to obtain multiple short-term training periods during their degree program, which may be consecutive or reserved for summers or other off-quarter periods.\n   \n4. **Application Requirement:**\n   - Short-term positions must be specifically requested in the T32 application.\n   \n5. **Stipends and Support:**\n   - Stipends and other support levels follow the NIH Guide for Grants and Contracts (Documents 1, 2, 3, 4, 5, 6, 7, 8, Section 11.3.2.5.3).\n\n**Summary:**\n\n- Short-term T32 positions are designed for health-professional students and quantitative science graduate students who have completed at least one academic term and are in good standing.\n- The training is full-time, lasting between 8 and 12 weeks, usually during summer or off-quarter periods.\n- Applicants must request these positions explicitly in their T32 grant applications.\n- Some NIH ICs may not support short-term T32 positions or may limit support, so prior consultation with the relevant IC is recommended.\n\nThis information is synthesized primarily from Section 11.3.2.5.3 of the NIH Ruth L. Kirschstein National Research Service Awards terms and conditions (Documents 1 through 8) and is consistent across multiple documents. Additional applicant eligibility context is provided in Documents 9 and 10 (Section 11.3.2.1).\n\n**References:**\n\n- Documents 1-8, Section 11.3.2.5.3 (Short-Term Research Training)\n- Documents 9-10, Section 11.3.2.1 (Applicant Eligibility)"}
{"id": "applied_medium_22", "question": "What must be included in the summary schedule of prior audit findings as required by \u00a7 200.511(b)?", "prediction": "The summary schedule of prior audit findings, as required by \u00a7 200.511(b), must include the following elements:\n\n1. **Status of All Prior Audit Findings**  \n   It must report the status of all audit findings included in the prior audit's:  \n   - Schedule of findings and questioned costs.  \n   - Summary schedule of prior audit findings from the prior audit, except those findings that have been listed as corrected in accordance with \u00a7 200.511(b)(1).  \n   (See Documents 9 and 10, Section 200.516(b))\n\n2. **Fiscal Year of Initial Occurrence**  \n   Since the summary schedule may include audit findings from multiple years, it must include the fiscal year in which each finding initially occurred.  \n   (See Documents 9 and 10, Section 200.516)\n\n3. **Inclusion of Financial Statement Findings**  \n   The summary schedule must include financial statement findings that the auditor was required to report under Generally Accepted Government Auditing Standards (GAGAS).  \n   (See Documents 9 and 10, Section 200.516)\n\n4. **Preparation Consistent with Major Program Requirements**  \n   The auditee prepares the summary schedule consistent with the requirements for major programs as outlined in \u00a7 200.514.  \n   (Synthesis)\n\n5. **Auditor's Follow-up and Assessment**  \n   The auditor must follow up on prior audit findings and assess the reasonableness of the summary schedule. If the auditor concludes that the summary schedule materially misrepresents the status of any prior audit finding, this must be reported as a current-year audit finding.  \n   (See Documents 5, 6, 7, 8, Section 200.511; Synthesis)\n\nIn summary, the summary schedule of prior audit findings must comprehensively report the status of all unresolved prior audit findings (except those corrected), specify the fiscal year each finding originated, include financial statement findings required by GAGAS, be prepared consistent with major program requirements, and be subject to auditor review and validation to ensure accuracy and completeness.\n\n**References:**  \n- \u00a7 200.511(b) and (b)(1) (Documents 9 and 10, Section 200.516)  \n- Auditor follow-up requirements (\u00a7 200.511) (Documents 5-8)  \n- Preparation requirements consistent with \u00a7 200.514 (Synthesis)"}
{"id": "applied_medium_23", "question": "What does it mean when a clear title is withheld by a Federal agency under 2 CFR 200.327?", "prediction": "Under 2 CFR 200.327, when a Federal agency withholds clear title to real property acquired or improved under a Federal award, it means that the Federal agency retains legal ownership or control over that property rather than transferring full ownership rights (clear title) to the recipient of the Federal funds. This withholding of clear title is a mechanism by which the Federal agency protects its interest in the property to ensure that it is used in accordance with the terms and conditions of the Federal award.\n\nKey points about what it means when clear title is withheld by a Federal agency under 2 CFR 200.327 include:\n\n1. **Retention of Ownership or Control by the Federal Agency**: The Federal agency maintains legal ownership or control over the property, rather than the recipient having full ownership rights. This ensures the Federal government\u2019s investment is safeguarded.\n\n2. **Imposition of Conditions and Restrictions**: The agency may impose specific conditions or restrictions on how the property is used, managed, or disposed of. These conditions are intended to ensure the property continues to serve the Federal program\u2019s purposes or complies with regulatory requirements.\n\n3. **Compliance Requirements for the Recipient**: The recipient must comply with Federal regulations related to the property, including requirements for reporting, maintenance, and possibly returning or transferring the property under certain conditions. This compliance is necessary to maintain accountability for the Federal investment.\n\n4. **Reasons for Withholding Clear Title**: Clear title may be withheld if the property is essential for the continued use of a Federal program or if the agency determines that retaining title is necessary to maintain program integrity and protect Federal interests.\n\n5. **Audit and Oversight**: Audits of the recipient must verify compliance with property management requirements, including any restrictions due to withheld clear title. Any findings related to property title issues must be documented with clear criteria, conditions, causes, effects, and recommendations (see 2 CFR 200.516).\n\n6. **Related Regulatory Terms**: The concept of \"Federal program\" (2 CFR 200.1) defines the Federal award under which the property was acquired, and \"prior approval\" (2 CFR 200.1) may be required for changes in use or disposition of property with withheld clear title.\n\nIn summary, withholding clear title under 2 CFR 200.327 means the Federal agency retains ownership/control of property acquired with Federal funds, imposes conditions to protect Federal interests, and requires the recipient to comply with regulations to ensure proper use and accountability of the property (Synthesis on 2 CFR 200.327).\n\nNo additional detailed procedural or legal text was provided in the retrieved documents, but the synthesis captures the essential meaning and implications of withholding clear title under this regulation."}
{"id": "applied_medium_24", "question": "What is the primary purpose of the Budget IIA-62 section in NIH grant compliance?", "prediction": "The primary purpose of the Budget IIA-62 section in NIH grant compliance is to establish the **standard administrative terms and conditions** that apply broadly and generally to all NIH grants and cooperative agreements. This section, part of Subpart A (IIA) of the NIH Grants Policy Statement (NIHGPS), serves as a foundational framework to ensure that NIH grant recipients comply with applicable federal statutes, regulations (including 2 CFR Part 200), and NIH-specific policies. It promotes responsible management and administration of federal funds by NIH recipients, ensuring adherence to public policy requirements and appropriation mandates.\n\nKey aspects of the Budget IIA-62 section include:\n\n1. **Standardization and Uniformity**: It incorporates terms and conditions by reference into all NIH awards, creating consistency across NIH grant administration (Documents 5, 6, 7, 8).\n\n2. **Compliance Framework**: It supplements statutory and regulatory requirements with NIH-specific policies, helping recipients understand and meet their obligations under federal law and NIH policy (Documents 5, 6, 7, 8).\n\n3. **Public Policy and Appropriation Mandates**: It enforces public policy objectives such as preventing improper financial gain, ensuring ethical and safe research environments, and fostering responsible stewardship of federal funds (Documents 9, 10; SYNTHESIS).\n\n4. **Administrative Guidance**: It provides guidance on administrative requirements, including changes in project scope and budget management, supporting effective grant oversight (SYNTHESIS).\n\n5. **Supplementation by Other Terms**: While Budget IIA-62 sets general terms, Subpart B (IIB) may expand or specify additional or alternate terms for particular award types or recipients, and award-specific terms may also apply (Documents 5, 6, 7, 8).\n\nIn summary, the Budget IIA-62 section functions as the core set of general terms and conditions that govern NIH grant awards, ensuring recipients manage NIH funds responsibly and in compliance with all relevant federal laws, regulations, and NIH policies. It is essential for maintaining uniformity, legal compliance, and alignment with public policy objectives across all NIH-funded projects (SYNTHESIS; Documents 5, 9, 10).\n\n**References:**\n- NIH Grants Policy Statement, Part II, Subpart A (IIA) (Documents 5, 6, 7, 8)\n- Public Policy Requirements and Objectives (Documents 9, 10)\n- Synthesis summary of Budget IIA-62 section"}
{"id": "applied_medium_25", "question": "Which sections of 2 CFR Part 200 apply to program-specific audits according to \u00a7 200.507(d)?", "prediction": "According to \u00a7 200.507(d) of 2 CFR Part 200, program-specific audits\u2014those audits conducted for a particular Federal program rather than a comprehensive single audit covering all Federal awards\u2014must comply with the audit requirements set forth in **Subpart F of 2 CFR Part 200**, except where otherwise provided.\n\n**Subpart F\u2014Audit Requirements** includes the general audit standards and procedures that apply to audits of non-Federal entities receiving Federal awards. The key elements of Subpart F that apply to program-specific audits include:\n\n- **General audit requirements** such as audit scope, auditor qualifications, and audit procedures.\n- Compliance with **Generally Accepted Government Auditing Standards (GAGAS)**.\n- Requirements for **audit reporting and submission** to Federal agencies and clearinghouses.\n- Provisions related to **cost principles and allowable costs** to ensure that costs charged to Federal awards are reasonable and allowable.\n\nThus, program-specific audits must adhere to these standards and requirements outlined in Subpart F, ensuring consistency with federal audit standards and compliance expectations. This means that although program-specific audits focus on a single Federal program, they are not exempt from the comprehensive audit standards that govern Single Audits; rather, they follow the same audit framework detailed in Subpart F unless explicitly exempted.\n\nThis interpretation is supported by the synthesis of the retrieved documents, which consistently emphasize that \u00a7 200.507(d) mandates program-specific audits to follow the audit requirements in Subpart F of 2 CFR Part 200 (see [SYNTHESIS]).\n\n**In summary:**\n\n- Program-specific audits under \u00a7 200.507(d) must comply with the audit requirements in **Subpart F of 2 CFR Part 200**.\n- Subpart F covers all general audit requirements, including audit scope, auditor qualifications, audit standards (GAGAS), reporting, and cost principles.\n- This ensures program-specific audits maintain the same level of rigor and compliance as Single Audits, tailored to the specific Federal program audited.\n\n**References:**\n\n- \u00a7 200.507(d) \u2014 Program-specific audits must comply with Subpart F requirements.\n- Subpart F \u2014 Audit Requirements (general audit standards, GAGAS compliance, reporting, cost principles).\n- [SYNTHESIS] document summarizing these points.\n\nNo additional specific section numbers within Subpart F are cited in the retrieved documents, but the entire Subpart F is indicated as applicable to program-specific audits per \u00a7 200.507(d)."}
{"id": "applied_medium_26", "question": "What should applicants ensure regarding application requirements and due dates according to NIH GPS section 11.2.3?", "prediction": "According to NIH GPS section 11.2.3 on Application Requirements and Due Dates, applicants should ensure the following:\n\n1. **Careful Review and Compliance**: Applicants must thoroughly review and comply with all specific application requirements outlined for the particular funding opportunity. This includes understanding eligibility criteria, application format, content, and any special instructions unique to the opportunity.\n\n2. **Timely Submission**: Applications must be submitted by the stated due dates. Late applications are generally not accepted, and failure to meet deadlines can result in rejection without review.\n\n3. **Correct Application Forms and Procedures**: Use the correct application forms and follow the submission procedures exactly as specified in the funding announcement.\n\n4. **Verification of Supporting Documents**: Ensure that all supporting documents meet the instructions provided, including format and content requirements.\n\n5. **Monitoring for Updates**: Applicants should monitor for any updates or changes to application requirements or deadlines issued by NIH to avoid missing critical information.\n\n6. **Consequences of Non-Compliance**: Failure to adhere to these requirements or due dates can lead to the application being rejected without review.\n\nThese points are synthesized from the information provided in the retrieved documents, specifically referencing section 11.2.3 titled \"Application Requirements and Due Dates\" (Documents 5, 6, 7, and 8). The emphasis is on strict adherence to instructions and deadlines to ensure the application is considered.\n\nIn summary, applicants must carefully follow all instructions, use the correct forms, submit on time, and stay informed of any changes to avoid disqualification of their application."}
{"id": "applied_medium_27", "question": "What are the reporting requirements for grants awarded to for-profit organizations under NIH guidelines?", "prediction": "Under NIH guidelines, the reporting requirements for grants awarded to for-profit organizations are governed primarily by the NIH Grants Policy Statement (NIHGPS), specifically detailed in Part II, Chapter 19, which addresses grants to for-profit organizations (Docs 4, 5, 7, 8, 9, 10). The key reporting and compliance requirements include the following:\n\n1. **General Public Policy and Compliance Requirements:**\n   - For-profit recipients must comply with NIH public policy requirements and appropriation mandates that apply broadly to all NIH grant recipients unless exceptions are specifically noted (Docs 1, 2).\n   - These include adopting and enforcing policies to prevent improper financial gain and conflicts of interest that could compromise research integrity.\n   - Recipients are also required to provide safe and healthful working conditions and foster environments conducive to high-quality research (Docs 1, 2).\n\n2. **Responsibility and Qualification Reporting:**\n   - For-profit organizations with currently active Federal awards (including NIH grants, cooperative agreements, and procurement contracts) totaling more than $10 million must comply with additional reporting requirements under Public Law 112-239 (the National Defense Authorization Act for Fiscal Year 2013).\n   - This involves maintaining up-to-date responsibility and qualification information in the System for Award Management (SAM.gov), as specified in Appendix XII to 2 CFR Part 200 (Docs 2, 3, 4, 5, 6).\n\n3. **Terms and Conditions Flow-Down:**\n   - The terms and conditions of NIH awards, including reporting requirements, apply not only to the primary for-profit recipients but also flow down to any subawards and subrecipients unless otherwise specified (Docs 4, 5, 7, 8).\n\n4. **Documentation and Guidance:**\n   - The NIH Grants Policy Statement (NIHGPS) is the authoritative source for detailed terms, conditions, and reporting requirements for NIH grants to for-profit organizations.\n   - The NIHGPS is organized into three parts: Part I (general information), Part II (terms and conditions, including those specific to for-profit organizations), and Part III (points of contact) (Docs 4, 5, 7, 8, 9, 10).\n\n**Summary:**\nFor-profit organizations awarded NIH grants must adhere to the same fundamental public policy and appropriation mandates as other recipients, including conflict of interest policies and workplace safety. They have additional reporting obligations if their total Federal awards exceed $10 million, requiring them to maintain current responsibility and qualification data in SAM.gov. Detailed reporting requirements and terms are specified in Part II, Chapter 19 of the NIH Grants Policy Statement, which also governs the flow-down of these requirements to subrecipients.\n\n**References:**\n- NIH Grants Policy Statement, Part II, Chapter 19 (Docs 4, 5, 7, 8, 9, 10)\n- Public Policy Requirements and Appropriation Mandates (Docs 1, 2)\n- Responsibility/Qualification Reporting under Public Law 112-239 and 2 CFR Part 200 (Docs 2, 3, 4, 5, 6)"}
{"id": "applied_medium_28", "question": "What are indirect costs according to 2 CFR Appendix IV to Part 200, and how should minor direct costs be treated?", "prediction": "According to 2 CFR Appendix IV to Part 200, **indirect costs** are defined as:\n\n- Costs that have been incurred for common or joint objectives and cannot be readily identified with a particular final cost objective.  \n- These are expenses that benefit multiple activities or projects and are not directly assignable to a single award or function.  \nThis definition is explicitly stated in Appendix IV to Part 200 under the section \"Allocation of Indirect Costs and Determination of Indirect Cost Rates\" (Documents 5, 6, 7, 8).\n\nRegarding the **treatment of minor direct costs**, the regulation allows:\n\n- Direct costs of minor amounts may be treated as indirect costs for practical reasons.  \n- This treatment is permitted to simplify accounting when the cost is insignificant and does not materially affect the allocation of costs.  \nThis is also noted in the same section of Appendix IV to Part 200 (Documents 5-8).\n\nAdditional context from the documents explains that indirect cost rates are used to allocate indirect costs to direct cost bases fairly and may be predetermined, fixed, provisional, or final rates depending on the circumstances (Documents 1-4). Separate indirect cost pools and rates may be established for different segments of work if those segments generate significantly different levels of indirect costs.\n\n**Summary:**\n\n- **Indirect costs** are shared costs incurred for common or joint objectives that cannot be directly assigned to a single project or award.  \n- **Minor direct costs** may be treated as indirect costs to simplify cost allocation when such costs are insignificant.  \n- Indirect cost rates are negotiated and applied to allocate these costs fairly across programs.\n\n**References:**\n\n- 2 CFR Appendix IV to Part 200, Section B.1 (Documents 5-8)  \n- 2 CFR Appendix III to Part 200, Section 5.C.1 (Documents 1-4)"}
{"id": "applied_medium_29", "question": "How much tuition and fees funding does NIH provide for an individual predoctoral fellowship applicant requesting $20,000 per year for a combined M.D.-Ph.D. program?", "prediction": "For an individual predoctoral fellowship applicant (such as F30 or F31) enrolled in a formally combined dual-degree program like an M.D.-Ph.D., the NIH provides tuition and fees funding according to the following policy:\n\n- NIH will fund **60% of the tuition and fees amount requested** by the sponsoring institution.\n- There is a **cap of up to $21,000 per year** for formally combined dual-degree programs (e.g., M.D.-Ph.D., D.D.S.-Ph.D.).\n- Health insurance costs are excluded from tuition and fees and are covered separately under the Institutional Allowance budget category.\n\nIn the specific case where the applicant requests $20,000 per year for tuition and fees in a combined M.D.-Ph.D. program:\n\n- NIH calculates 60% of $20,000, which equals $12,000.\n- Since $12,000 is below the $21,000 cap for dual-degree programs, NIH will fund the full 60% amount requested.\n- Therefore, NIH will provide **$12,000 per year** for tuition and fees funding for this applicant.\n\nAdditional relevant points include:\n\n- Tuition and fees must be applied consistently to all individuals in similar training status at the institution (Documents 9 and 10, Section 11.3.8.3).\n- Pre-award costs for tuition and fees are not allowed until the fellowship award is activated and the appropriate paperwork is submitted to NIH (Documents 1-4, Section 11.2.9.1).\n\nThis policy is summarized in multiple documents, including Sections 11.2.9.5 and 11.3.8.3, which state:\n\n> \"For individual predoctoral fellowships (F30 and F31), an amount equal to 60% of the level requested by the sponsoring institution, up to $16,000 per year, will be provided. If the program supports formally combined dual-degree training (e.g., M.D.-Ph.D., D.D.S.-Ph.D.), the amount provided will be up to $21,000 per year.\"  \n> (Documents 5-8, Section 11.2.9.5)\n\n**In summary:**  \nFor an individual predoctoral fellowship applicant in a combined M.D.-Ph.D. program requesting $20,000 per year for tuition and fees, NIH will provide **60% of the requested amount, i.e., $12,000 per year**, which is within the $21,000 cap for dual-degree programs (Documents 5-8, Section 11.2.9.5; Documents 9-10, Section 11.3.8.3).\n\n---\n\n**References:**  \n- Documents 5-8, Section 11.2.9.5 (Tuition and Fees Policy)  \n- Documents 9-10, Section 11.3.8.3 (Trainee Tuition and Fees)  \n- Documents 1-4, Section 11.2.9.1 (Pre-award Costs)"}
{"id": "applied_medium_30", "question": "What is the NIH policy on rebudgeting funds within a grant?", "prediction": "The NIH policy on rebudgeting funds within a grant generally allows recipients to rebudget funds within direct cost categories without prior NIH approval. However, there are important exceptions and conditions that must be observed:\n\n1. **General Rebudgeting Without Prior Approval:**\n   - Funds awarded on NIH grants, including Career Development Awards (CDAs), may typically be rebudgeted within direct cost categories without obtaining prior approval from NIH. This flexibility facilitates efficient management of grant funds to meet project needs. (Docs 3,4,5,6,7,8; Section 12.9)\n\n2. **Restrictions Requiring Prior NIH Approval:**\n   - **Alterations and Renovations (A&R) Costs:**\n     - If a recipient wishes to rebudget more than 25% of the total approved budget for a budget period into A&R costs, prior NIH approval is required. (Docs 1,2; Section 8.1.2.2)\n     - Even if the rebudgeting into A&R costs is less than 25%, prior approval is required if the rebudgeting results in a change in the project scope.\n     - Addition of a Major A&R project through rebudgeting is considered a change in scope and requires NIH approval. (Docs 1,2)\n   \n   - **Salary Funds Freed by Career Awards:**\n     - Rebudgeting of salary funds or fringe benefits of individuals that become available as a result of a career award cannot be done without prior approval from the NIH awarding Institute or Center (IC). (Docs 5,6,7,8; Section 12.9)\n\n3. **Change in Project Scope:**\n   - Any rebudgeting that results in a change in the scope of the project requires prior NIH approval. This is a critical compliance point to ensure that the project remains consistent with the originally approved aims and objectives. (Docs 1,2)\n\n4. **Compliance with Terms, Conditions, and Statutes:**\n   - NIH recipients must comply with all terms and conditions of the award, including statutory, regulatory, and appropriation mandates that govern the use and rebudgeting of funds. These include the NIH Grants Policy Statement (NIHGPS), 2 CFR Part 200, and award-specific terms. (Docs 3,4,5,6,7,8,9,10)\n   - Recipients are responsible for ensuring that rebudgeting actions do not violate any public policy requirements or appropriation mandates. (Docs 3,4,9,10)\n\n5. **Notice of Award (NoA) Specific Restrictions:**\n   - The Notice of Award may specify additional restrictions or special conditions on rebudgeting. Recipients must review the NoA carefully to identify any such conditions. (Docs 5,6,7,8; Section 12.9)\n\n**Summary:**\n- NIH allows rebudgeting within direct cost categories without prior approval in most cases.\n- Prior NIH approval is required when:\n  - Rebudgeting more than 25% of the budget into Alterations and Renovations (A&R) costs.\n  - Rebudgeting into A&R costs results in a change in scope or involves adding a Major A&R project.\n  - Rebudgeting salary funds freed by career awards.\n  - Any rebudgeting that changes the project scope.\n- All rebudgeting must comply with NIH policies, terms and conditions, and applicable statutes and appropriation mandates.\n- Recipients must also adhere to any additional restrictions noted in the Notice of Award.\n\n**References:**\n- Alterations and Renovations rebudgeting restrictions: Docs 1,2 (Section 8.1.2.2)\n- General rebudgeting policy and salary fund restrictions: Docs 3,4,5,6,7,8 (Section 12.9)\n- Compliance with policies and appropriation mandates: Docs 3,4,9,10\n- Notice of Award conditions: Docs 5,6,7,8 (Section 12.9)\n\nThis comprehensive policy framework ensures responsible and compliant management of NIH grant funds while providing flexibility for recipients to adjust budgets as needed within established guidelines."}
